Background
==========

Chronic granulomatous disease is a hereditary disorder that disrupts neutrophil activity. The disease is characterized by recurrent infections and a myriad of inflammatory complications ([@B6]). CGD is caused by mutations in genes responsible for the superoxide-generating phagocyte NADPH oxidase. This results in the absence of, or very low levels of enzyme activity in neutrophils, increasing susceptibility to infection and allowing for the proliferation of systemic granulomatous disease. The incidence of CGD is rare with 1 in 200 000 live births ([@B5]). More than two-thirds of all cases are linked to defects in the CYBB gene acquired in an X-linked recessive manner. The remaining cases are autosomal recessive inherited diseases caused by defects in *CYBA*, *NCF-1*, and *NCF-2* genes ([@B5]).

Williams--Beuren syndrome is a segmental aneusomy syndrome which results from a heterozygous deletion of numerous genes within the 7q11.23 region ([@B2]). The phenotype of this syndrome includes growth retardation, facial dysmorphies, heart abnormalities, hyperacusis, infantile hypercalcemia, and abnormal gait. Cardiac abnormalities typically involve SVAS and peripheral pulmonary stenosis ([@B12]). Patients have severe deficits in cognitive domains; personality is characterized by readiness to interact with strangers and overt friendliness. Approximately 70% exhibit attention deficit disorder ([@B12]).

Case Presentation
=================

A 19-years-old patient was transferred to our pediatric hospital for further diagnostic analysis from a clinic specialized in adult lung diseases. The afebrile patient suffered from a dry, non-productive cough. An intrathoracic inflammatory granulomatous mass was localized by radiogram and computer tomography (**Figure [1](#F1){ref-type="fig"}**). Serum levels of soluble interleukin 2 receptor, neopterin, and angiotensin converting enzyme were negative. Bronchoalveolar lavage fluid showed lymphocytosis. Transbronchial biopsy revealed chronic, partly granulomatous inflammation with no signs of necrosis (**Figure [2](#F2){ref-type="fig"}**). No mycobacteria were found and the results were not typical for sarcoidosis. Steroid and antibiotic (cotrimoxazol) therapy resulted in rapid resolution of the intrathoracic mass.

![Patient's X-ray (left) and chest-CT (right) showing a left upper lobe mass near the mediastinum resulting in a dry, non-productive cough.](fgene-09-00355-g001){#F1}

![Histology sample of the intrathoracic mass showing granulomatous inflammation.](fgene-09-00355-g002){#F2}

The patient's past medical history included the diagnosis of a learning disability (patient currently attends special-needs school). Phenotypical dysmorphic facies had been noted including broad forehead, bi-temporal narrowing, strabismus, long philtrum, wide mouth, and large ear lobes (**Figure [3](#F3){ref-type="fig"}**). No further assessment of the patient's cognitive abilities had been performed; however, clinically a mild intellectual disability was observed. MRS (OMIM 155900) and Crohn's disease (OMIM 266600) had previously been diagnosed. MRS was histologically diagnosed at the age of 10 when the patient presented with swelling of the upper lip and granulomatous inflammation. However, typical features, such as lingua plicata or facialis paresis were not noted ([@B1]). Intense therapy with dapson, infliximab, azathioprine, and steroids led only to intermittent improvement. Crohn's disease was diagnosed by screening at the age of 17, as two aunts had previously been diagnosed with Crohn's disease (**Figure [4](#F4){ref-type="fig"}**). The patient had neither diarrhea nor significant gastrointestinal complaints. Colonoscopic biopsies revealed epithelial cell granulomas compatible with Crohn's disease (see **Table [1](#T1){ref-type="table"}**).

![Facial phenotype of patient with upper lip granuloma and dysmorphic facies (symptoms of Williams--Beuren syndrome).](fgene-09-00355-g003){#F3}

![Family pedigree: the patient (only child) is at the bottom. Paternal information is missing -- father does not reside with the family. The *NCF-1* gene was also heterozygous for the father. The mother's sisters -- marked with black dot -- were both diagnosed with Crohn's disease.](fgene-09-00355-g004){#F4}

###### 

Differential diagnosis of CGD and fundamental differences to other diagnoses.

  Differential Diagnosis of CGD                                                       
  ----------------------------------- ------------------- ----- --------------- ----- -------------------------------------------
  Chronic granulomatous Disease       Systemic            Yes   Opportune       Yes   --
  Cystic fibrosis                     Lung (infections)   Yes   Opportune       No    Infection limited to lung, bronchiectasis
  Hyperimmunoglobulin E syndrome      Lung (infections)   Yes   Staphylococci   No    Characteristic facies, elevated IgE
  G6PD deficiency                     Systemic            Yes   Bacterial       Yes   Hemolytic anemia
  Glutathione synthetase deficiency   Systemic            Yes   Bacterial       Yes   Hemolytic anemia, acidosis, ment. retard.
  Crohn's disease                     Bowel               No    --              No    CGD has no extraintestinal symptoms

A multisystem granulomatous disease was suspected; therefore, the patient was tested for CGD using a dihydrorhodamine 123 (DHR) assay. This assay revealed a considerable decrease in NADPH-oxidase activity. Subsequent Sanger sequencing identified the most common mutation within the *NCF-1* gene (OMIM 608512: c.75.76delGT; p.Tyr26HisfsX26, chromosome 7, 7q11.23). The mutation was confirmed as heterozygous for the father, but surprisingly not for the mother. Unfortunately, symptomatic data for the father are unknown, as he does not reside with the family (**Figure [4](#F4){ref-type="fig"}**). The patient was administered the recommended prophylactic therapy of cotrimoxazol and itraconazol.

Nevertheless, neither learning disability nor facial dysmorphism are associated with CGD. The dysmorphism raised suspicion of WBS despite the absence of cardiac symptoms. Upon further genetic analysis, fluorescence *in situ* hybridization revealed microdeletions within 7q11.23 \[46,XY.ish del(7)(q11.23q11.23)(ELN-)\](OMIM 194050) with locus specific deletions; this confirmed the diagnosis of WBS.

Discussion
==========

The patient presented with granuloma formation in three different sites: lung, colon, and upper lip. This led to the differential diagnosis of CGD confirmed by DHR assay and *NCF-1* gene analysis. The clinical course of our patient differed from most CGD patients, due to the fact that *NCF-1*- (p47phox-) deficient CGD is generally associated with residual NADPH activity. This may explain why our patient had no history of life-threatening infection even while under immunosuppressive therapy aimed at treating previously suspected MRS. However, although *NCF-1*-deficient CGD generally follows a milder course than CGD lacking residual activity, some infectious manifestations can be equally as severe and life threatening as those contracted during the course of classical CGD, e.g., invasive aspergillus infections of the lungs ([@B5]).

The diagnosis of CGD alone did not account for all of our patient's symptoms; instead, some underlying features such as facial dysmorphism and cognitive disability pointed toward WBS. We therefore expanded the genetic analysis and were able to confirm WBS. Our patient could then be treated appropriately for this disorder; treatment includes physical, developmental, and speech therapy ([@B8]; [@B2]; [@B12]). WBS usually occurs sporadically and is the result of heterozygous deletions of contiguous genes located close to the gene locus of CGD at 7q11.23. In the majority of patients, approximately 30 genes are missing ([@B2]; [@B5]).

The region depicted in **Figure [5](#F5){ref-type="fig"}** is highly repetitive already in non-human primates -- compared to other mammals -- and even more so in humans. Three large region-specific segmental duplications (centromeric, medial, and telomeric LCRs) with genetic variations have been identified. Each segmental duplication is composed of three differentiated blocks designated as "A," "B," and "C" ([@B2]; [@B5]). Several genes and their unprocessed highly similar pseudogenes such as *NCF-1* are located centromeric and telomeric to the critical WBS region (see [@B7]) Depending on gene arrangement, several disorders may arise due to similar mechanisms. For example, a loop can be formed by pairing a region centromeric to the WBS stretch with a highly similar telomeric region. If the loop is removed enzymatically in a cellular DNA repair attempt, the microdeletion syndrome WBS results ([@B9]). *NCF-1* can be involved in a loop larger than 1.5 Mb and also be deleted. Another mechanism with a similar result would be a pairing of such regions centromeric and telomeric to WBS between sister chromosomes 7 and subsequent unequal crossover. On a smaller scale, a recombination of the wildtype *NCF-1* gene with one of its pseudogenes could lead to a deletion or a partial deletion of the wildtype *NCF-1* gene ([@B9]). Alternatively, after pairing with one of its pseudogenes, both harboring the GT-deletion at the beginning of exon 2, the wildtype gene could be converted into a pseudogene by DNA repair mechanisms in such a way that the GT-deletion moves into the wildtype gene. These possible rearrangements are difficult to detect by simple DNA sequencing of the critical *NCF-1* region, as the GT-deletions of the highly similar pseudogenes misrepresent the sequence information. The recombination of the wildtype with a pseudogene also generates a high number of *NCF-1*-deficient CGD carriers in the general population (ca. 1:700 in all ethnic groups) ([@B9]).

![Transcript map of the Williams--Beuren syndrome critical region with the NCF1 gen (red) ([@B12]).](fgene-09-00355-g005){#F5}

These considerations apply to our patient in the following way: One allele of his 7q11.23 region harbors a large deletion of the critical WBS region that involves the *NCF-1* gene. The other allele harbors the frequent GT-deletion in exon 2 (c.75.76delGT) of the *NCF-1* wildtype gene. The mutation in *NCF-1* occurs then in the heterozygous state. Note that the WBS is normally caused by a *de novo* microdeletion, whereas the *NCF-1*-deficient CGD is inherited in an autosomal recessive manner. We find it remarkable that our patient is afflicted by two separate disorders that share a common background: Gene duplication (and triplication) with genetic variation in the region 7q11.23 during evolution and more recently as a result of recombination events between these regions.

It has been reported that a functional *NCF-1* gene increases the risk of hypertension in patients with WBS. It has also been found that the hemizygosity in *NCF-1* gene decreases this risk ([@B3]); yet, most of these patients do not exhibit CGD. Only four individuals with this condition have been reported. All were previously diagnosed with WBS, two presented with symptoms of chronic granulomas during adolescence when diagnosed with CGD, and one exhibited CGD symptoms during early childhood ([@B4]; [@B11]).

Conclusion
==========

It is important to be aware of possible clinical indications suggestive of WBS in patients with *NCF-1*-deficient CGD. The identification of disease causing mutations using in-depth genetic analysis will facilitate the initiation of appropriate therapy for patients who are afflicted by these and other hereditary disorders.
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:   interferon
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:   reduced nicotinamide adenine dinucleotide phosphatase

NCF

:   neutrophil cytosolic factor
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